Akari Therapeutics Income Statement (2011-2026) | AKTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Dec2021	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	0.01B	0.00B	0.00B	-0.00B	0.00B			0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B
Selling, General & Administrative (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.10B	0.00B	0.00B	0.00B	0.00B	0.00B
Restructuring Costs (Quarter)													0.00B	0.00B	0.00B
Other Operating Expenses (Quarter)												-0.01B	-0.01B	-0.00B	-0.00B					0.01B
Operating Expenses (Quarter)	0.01B	0.00B	0.01B	0.00B	0.01B			0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.00B	0.11B	0.00B	0.00B	0.00B	0.00B	0.02B
Operating Income (Quarter)	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B			-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.11B	-0.00B	-0.00B	-0.01B	-0.00B	-0.02B
EBIT (Quarter)	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B			-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.11B	-0.00B	-0.00B	-0.01B	-0.00B	-0.02B
Non-operating items
Non Operating Investment Income (Quarter)																				0.00B
Interest & Investment Income (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B			0.00B
Other Non Operating Income (Quarter)	0.00B	0.00B	0.00B	0.00B	-0.00B			-0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	-0.03B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B
Non Operating Income (Quarter)	-0.00B	0.00B	-0.00B	0.00B	0.00B			-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	-0.03B	-0.00B	0.00B	-0.00B	-0.00B	0.00B
Net income details
EBT (Quarter)	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B			-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.02B
Tax Provisions (Quarter)																		-0.00B	0.00B	-0.00B
Profit After Tax (Quarter)	-0.01B	-0.00B	-0.01B	0.00B	-0.01B			0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.00B	-0.14B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B
Income from Continuing Operations (Quarter)	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B			-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B
Consolidated Net Income (Quarter)	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B			-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B
Income towards Parent Company (Quarter)	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B			-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B
Net Income towards Common Stockholders (Quarter)	-0.01B	-0.00B	-0.01B	-0.00B	-0.01B			-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B
Additional items
EPS (Basic) (Quarter)	0.00	0.00	0.00	0.00	-0.01			0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-3.16	0.00
EPS (Weighted Average and Diluted) (Quarter)	0.00				0.00			0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Shares Outstanding (Weighted Average) (Quarter)	1.83B	2.52B	2.76B	3.39B	3.16B	4.29B	6.24B	7.47B	8.79B	10.12B	9.79B	13.45B	16.14B	18.91B	23.89B	54.59B	62.94B	60.97B	0.00B	118.76B
Shares Outstanding (Diluted Average) (Quarter)	1.83B				3.16B	4.29B	6.24B	7.57B	8.79B	10.12B	9.79B	13.45B	18.84B	24.39B	23.89B	54.59B	58.77B	60.97B	67.33B	118.76B
EBITDA (Quarter)	0.00B	-0.00B	-0.01B	0.00B	-0.01B			0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.01B
Interest Expenses (Quarter)													0.00B	0.00B	0.03B	0.00B	0.00B	0.00B	0.00B	0.00B
Tax Rate (Quarter)																		14.53%	-1.63%	5.61%

Research Tools

Developers

Akari Therapeutics Income Statement (2011-2026) | AKTX

Research Tools

Developers

Akari Therapeutics Income Statement (2011-2026) | AKTX

Create an account

Sign In

Reset Password